GlossaryEvidence & ResearchN=1 Study
Evidence & Research

N=1 Study

Also known as: N-of-1 · single-subject study

An N=1 study is a structured experiment in a single person; the rigorous form, an N-of-1 trial, alternates treatment and control periods in random order.

In clinical research, an N-of-1 trial is a crossover trial in one patient. The design described in 1986 gives a single patient a series of paired treatment periods, one active and one placebo or alternative in each pair, with the order decided at random and both patient and clinician blinded. A target outcome (a symptom, a sign or a lab test) is measured in each period, and the trial continues until a benefit is shown or ruled out. CENT, a reporting standard for these trials, was published in 2015 as an extension of CONSORT.

Outside a clinic, "N=1" often just means self-tracking. A structured version keeps the core features: a baseline, one change at a time, outcomes chosen in advance, regular measurement, and repeated on and off periods. A 2024 review of 74 randomized N-of-1 trials published between 2011 and 2023 found a median of six periods; 77% used blinding, 66% were placebo-controlled and 43% included a washout period.

Why it matters

Group trials report average effects, and you may respond differently from the average. A well-run N-of-1 trial answers a narrower question that a group trial cannot: does this help me? An unstructured self-experiment, though, lacks the features that make that answer believable, such as blinding, a randomized order, washouts and a single change at a time.

Without them, expectation and regression to the mean (unusually bad stretches drifting back toward normal on their own) can produce a convincing "result" from nothing. An N=1 also tells you about you, not about the compound in general, and it says little about rare or long-term harms. In DoseCraft's methodology, aggregated, structured self-report counts as Experimental-lane evidence.

How to structure one

  1. Pick one outcome you can measure the same way every time (a 0 to 10 symptom score, a lab value, a timed test) and decide it before you start.
  2. Record a baseline long enough to see your normal ups and downs.
  3. Change one thing at a time and keep training, diet, sleep and other compounds as steady as you can.
  4. Alternate on and off periods more than once, and set the order in advance, at random if you can.
  5. Leave a washout between periods long enough for the previous period's drug to clear; DoseCraft's half-life decay tool (/tools/half-life-decay) shows how much remains over time.
  6. Compare periods on the outcome you chose in advance, not whichever one looks best afterward.

Fraction of a dose remaining after n half-lives = 0.5^n

Worked example

After 5 half-lives, 0.5^5 = 0.031, so about 3% of the drug remains and about 97% is gone. For a compound with a 2-day half-life, that is 5 x 2 = 10 days. Effects can outlast the drug itself, so a washout based on half-life is a minimum, not a guarantee.

Common mistakes

  • Starting when symptoms are at their worst, so natural improvement looks like a treatment effect.
  • Changing several things at once and crediting the result to one of them.
  • Choosing what to measure after seeing the data.
  • Running one on period and one off period and calling the difference a result.
  • Generalizing a personal result to other people, or reading a short N=1 as evidence about long-term harms.

Sources

  1. Clinical trialDetermining optimal therapy--randomized trials in individual patients. N Engl J Med, 1986. PMID 2936958.
  2. GuidelineCONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ, 2015. PMID 25976398.
  3. ReviewA methodological review of randomised n-of-1 trials. Trials, 2024. PMID 38622638.

Page updated . How we grade evidence: methodology.

Related Terms

Anecdotal Report

An anecdotal report is one person's account of what happened after using something, collected without a control group or a set measurement plan.

Practitioner Corpus

The practitioner corpus is the practitioner and clinic protocol material in DoseCraft's sources; claims from it are labeled Expert, apart from trial evidence.

Three-Lane Evidence System

The three-lane evidence system is DoseCraft's method of labeling each claim by the strength of evidence behind it: Clinical, Expert or Experimental.

Look up any peptide term inside DoseCraft Pro

The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.

Start Free Trial